Waverley Pharma Inc V.WAVE

Healthcare Biotechnology

Waverley Pharma Inc. is a biopharmaceutical company engaged in the research, development, and commercialization of human therapeutics focused on oncology. Its primary focus is the PARP-1 program and secondary focus is the generic oncology injectable market in European Union, the United Kingdom (UK) and North America. It has entered into a license, manufacture, supply, marketing and distribution agreement with Reliance Life Sciences Private Limited, which has granted it an exclusive territorial license to market and sell capecitabine in the UK and Germany as well as a non-exclusive territorial license to market and sell temozolomide and erlotinib in the UK. Its generic oncology products include bortezomib and pemetrexed. Bortezomib is an injectable generic chemotherapy drug, developed for the treatment of multiple myeloma and mantle cell lymphoma. Pemetrexed is an injectable generic chemotherapy drug, developed for the treatment of non-small cell lung cancer and pleural mesothelioma.

TSXV:WAVE - Post by User

Waverley Pharma Inc > INSIDER

<< Previous

Bullboard Posts

Next >>

Post by THORZEUS2019on Jul 30, 2020 3:51pm

226 Views

Post# 31346132

INSIDER

So, Albert Friesen, who owns 40,282,000 shares (74.6% of the company) doesn;t look like he is selling. Company is debt free.. I think we have a winner. There will be a lot of profit taking, but in the end, this is a keeper...

<< Previous

Bullboard Posts

Next >>

REITS over single property investments